Complicated bleeding challenge and intraoperative safety strategies in a case of hemophilia a with rhabdomyosarcoma

Pediatr Hematol Oncol. 2022 Oct;39(7):672-677. doi: 10.1080/08880018.2022.2038316. Epub 2022 Feb 9.

Authors

Phumin Chaweephisal¹, Hansamon Poparn^{1

2}, Kanhatai Chiengthong^{1

2}, Panya Seksarn¹, Piti Techavichit^{1

2}, Supanun Lauhasurayotin^{1

2}, Darintr Sosothikul^{1

2}

Affiliations

¹ Division of Hematology and Oncology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
² Integrative and Innovative Hematology/Oncology Research Unit, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.

PMID: 35138216
DOI: 10.1080/08880018.2022.2038316

No abstract available

Keywords: Severe hemophilia A; pharmacokinetic-guided prophylaxis; pre-operative management; rhabdomyosarcoma.

Publication types

Case Reports
Letter

MeSH terms

Factor VIII / therapeutic use
Hemophilia A* / complications
Hemorrhage
Humans
Rhabdomyosarcoma* / complications
Rhabdomyosarcoma* / surgery
Rhabdomyosarcoma, Embryonal*

Substances

Factor VIII